Cargando…
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is conventionally characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2), accounting for approximately 15–20% of all breast cancers. Co...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520847/ https://www.ncbi.nlm.nih.gov/pubmed/37767463 http://dx.doi.org/10.2147/BTT.S426392 |